Carrie Strand

6PUBLICATIONS
90CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 04, 2026
Randomized, Double-Blind, Placebo-Controlled Trial of Meriva (Curcuminoids) as a Candidate Chemoprevention Agent for Gastric Carcinogenesis.

|Sep 03, 2025
Was It Worth It? Response Data from >650 US and International Participants in Chemoprevention Trials.

David Zahrieh, Carrie A Strand, Paul J Limburg

|Apr 15, 2025
Neoadjuvant cobimetinib and atezolizumab with or without vemurafenib for stage III melanoma: outcomes and the impact of the microbiome from the NeoACTIVATE trial.

Matthew S Block, Garth D Nelson, Jun Chen

|Mar 26, 2024
A Phase I Trial of Nab-Paclitaxel/Bevacizumab (AB160) Nano-Immunoconjugate Therapy for Gynecologic Malignancies.

Eleftheria Kalogera, Wendy K Nevala, Heidi D Finnes

|Mar 09, 2023
Randomized, Double-Blind, Placebo-Controlled Trial of MUC1 Peptide Vaccine for Prevention of Recurrent Colorectal Adenoma.

Robert E Schoen, Lisa A Boardman, Marcia Cruz-Correa

|Dec 19, 2022
Phase I Trial of a Therapeutic DNA Vaccine for Preventing Hepatocellular Carcinoma from Chronic Hepatitis C Virus (HCV) Infection.

Jeffrey M Jacobson, David Zahrieh, Carrie A Strand

Pageof 1

Frequent Collaborators

4 joint publications

Paul J Limburg

3 joint publications

David Zahrieh

3 joint publications

Marcia Cruz-Correa

3 joint publications

Luz Maria Rodriguez